Probiotics/synbiotics supplementation reduce the infection incidence in patients undergoing resection for colorectal cancer: an umbrella review
Authors:
Open Access
- 11 September 2025
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 16, 1635409
Abstract
Objectives: This study reviews meta-analyses of perioperative supplementation with probiotics/synbiotics in colorectal cancer (CRC), systematically assessing the quality of meta-analyses and synthesizing study results to provide robust evidence.Methods: This review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. The search was conducted by two authors in four databases, PubMed, CENTRAL, EMBASE and Web of Science, up until August 3rd, 2025, and conducted independent assessments of the methodological quality of the meta-analysis via A Measure Tool to Assess Systematic Reviews (AMSTAR) 2.Results: A total of 11 meta-analyses were included in this umbrella review. 3 meta-analyses rated “Critically low” shared ≥3 critical flaws and 2 high-rated reviews adhered to ≥80% AMSTAR 2 criteria. Compared with the control group, the probiotic/synbiotic group presented lower incidence rates of overall infections (OR 0.49, 95% CI: 0.43, 0.56; P < 0. 001, I2 = 6%), surgical site infections (OR 0.58, 95% CI: 0.50, 0.67; P < 0.00001, I2 = 0%), urinary tract infections (OR 0.39, 95% CI: 0.27, 0.54; P < 0.00001, I2 = 0%), and pneumonia infections (OR 0.34, 95% CI: 0.26, 0.45; P < 0.00001, I2 = 0%), and diarrhea incidence (OR 0.41, 95% CI: 0.34, 0.51; P < 0.00001, I2 = 0%).Conclusion: According to the results of our analyses, perioperative probiotic/synbiotic supplementation in CRC patients is associated with a reduced incidence of overall infections, surgical site infections, urinary tract infections, pneumonia infections, and diarrhea.Systematic review registration: https://www.crd.york.ac.uk/prospero/, identifier CRD42024619853.Keywords
This publication has 45 references indexed in Scilit:
- The anticancer effect of potential probiotic L. fermentum and L. plantarum in combination with 5-fluorouracil on colorectal cancer cellsWorld Journal of Microbiology and Biotechnology, 2024
- Perioperative or Postoperative Probiotics Reduce Treatment-Related Complications in Adult Colorectal Cancer Patients Undergoing Surgery: A Systematic Review and Meta-analysisJournal of Gastrointestinal Cancer, 2024
- Tumor-resident Lactobacillus iners confer chemoradiation resistance through lactate-induced metabolic rewiringCancer Cell, 2023
- Targeted lactate dehydrogenase genes silencing in probiotic lactic acid bacteria: A possible paradigm shift in colorectal cancer treatment?Biomedicine & Pharmacotherapy, 2023
- Probiotics and synbiotics for preventing postoperative infectious complications in colorectal cancer patients: a systematic review and meta-analysisTechniques in Coloproctology, 2022
- The anti-cancer effects and mechanisms of lactic acid bacteria exopolysaccharides in vitro: A reviewCarbohydrate Polymers, 2021
- Examining overlap of included studies in meta‐reviews: Guidance for using the corrected covered area indexResearch Synthesis Methods, 2019
- Importance of probiotics in the prevention and treatment of colorectal cancerJournal of Cellular Physiology, 2019
- Probiotic supplements might not be universally-effective and safe: A reviewBiomedicine & Pharmacotherapy, 2019
- Probiotics for preventing postoperative infection in colorectal cancer patients: a systematic review and meta-analysisInternational Journal of Colorectal Disease, 2018